SAFETY OF IXEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS: AN INTEGRATED ANALYSIS OF 4 CLINICAL TRIALS

被引：0
|
作者：
Sesin, C. [1 ]
Gallo, G. [2 ]
Gellett, A. [2 ]
Kronbergs, A. [2 ]
Sprabery, A. T. [2 ]
Xu, W. [2 ]
Patel, H. [2 ]
Deodhar, A. [3 ]
Combe, B. [4 ]
Burmester, G. R. [5 ]
机构：
[1] Mt Sinai Med Ctr, Miami Beach, FL 33140 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Montpellier Univ, CHU Montpellier, Montpellier, France
[5] Univ Klinikum Charite, Berlin, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.567
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1033
引用
收藏
页码：789 / 789
页数：1
相关论文
共 50 条
  • [1] SAFETY OF IXEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A POOLED ANALYSIS OF THREE CLINICAL TRIALS
    Goupille, P.
    Roussou, E.
    Burmester, G.
    Mease, P. J.
    Gottlieb, A. B.
    Garces, S.
    Benichou, O.
    Adams, D.
    Xu, W.
    Nash, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1039 - 1040
  • [2] Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials
    Mease, Philip
    Roussou, Euthalia
    Burmester, Gerd-Ruediger
    Goupille, Philippe
    Gottlieb, Alice
    Moriarty, Susan R.
    Benichou, Olivier
    Adams, David H.
    Xu, Wen
    Nash, Peter
    ARTHRITIS CARE & RESEARCH, 2019, 71 (03) : 367 - 378
  • [3] Safety Profile of Ixekizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis: Integrated Analysis of 18 Clinical Trials
    Genovese, Mark
    Kameda, Hideto
    Rahman, Proton
    Canete, Juan
    Garces, Sandra
    Xu, Wen
    Hufford, Matthew M.
    Combe, Bernard
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [4] Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis
    Bernard Combe
    Proton Rahman
    Hideto Kameda
    Juan D. Cañete
    Gaia Gallo
    Noah Agada
    Wen Xu
    Mark C. Genovese
    Arthritis Research & Therapy, 22
  • [5] Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis
    Combe, Bernard
    Rahman, Proton
    Kameda, Hideto
    Canete, Juan D.
    Gallo, Gaia
    Agada, Noah
    Xu, Wen
    Genovese, Mark C.
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [6] Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials
    Genovese, Mark C.
    Mysler, Eduardo
    Tomita, Tetsuya
    Papp, Kim A.
    Salvarani, Carlo
    Schwartzman, Sergio
    Gallo, Gaia
    Patel, Himanshu
    Lisse, Jeffrey R.
    Kronbergs, Andris
    Leage, Soyi Liu
    Adams, David H.
    Xu, Wen
    Marzo-Ortega, Helena
    Lebwohl, Mark G.
    RHEUMATOLOGY, 2020, 59 (12) : 3834 - 3844
  • [7] Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials
    Saxon D. Smith
    Alexandros Stratigos
    Matthias Augustin
    Jose Manuel Carrascosa
    Susanne Grond
    Elisabeth Riedl
    Wen Xu
    Himanshu Patel
    Mark Lebwohl
    Dermatology and Therapy, 2023, 13 : 1773 - 1787
  • [8] Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials
    Smith, Saxon D.
    Stratigos, Alexandros
    Augustin, Matthias
    Carrascosa, Jose Manuel
    Grond, Susanne
    Riedl, Elisabeth
    Xu, Wen
    Patel, Himanshu
    Lebwohl, Mark
    DERMATOLOGY AND THERAPY, 2023, 13 (08) : 1773 - 1787
  • [9] Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure
    Deodhar, Atul A.
    Combe, Bernard
    Accioly, Ana P.
    Bolce, Rebecca
    Zhu, Danting
    Gellett, Amanda M.
    Sprabery, Aubrey Trevelin
    Burmester, Gerd-Ruediger R.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (07) : 944 - 950
  • [10] Long-term safety of risankizumab in patients with psoriatic disease: Findings from integrated analyses of 17 clinical trials in psoriasis and 4 in psoriatic arthritis
    Gordon, Kenneth B.
    Blauvelt, Andrew
    Bachelez, Herve
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB78 - AB78
12345